Literature DB >> 24222945

Stages based molecular mechanisms for generating cholangiocytes from liver stem/progenitor cells.

Wei-Hui Liu1, Li-Na Ren, Tao Chen, Li-Ye Liu, Li-Jun Tang.   

Abstract

Except for the most organized mature hepatocytes, liver stem/progenitor cells (LSPCs) can differentiate into many other types of cells in the liver including cholangiocytes. In addition, LSPCs are demonstrated to be able to give birth to other kinds of extra-hepatic cell types such as insulin-producing cells. Even more, under some bad conditions, these LSPCs could generate liver cancer stem like cells (LCSCs) through malignant transformation. In this review, we mainly concentrate on the molecular mechanisms for controlling cell fates of LSPCs, especially differentiation of cholangiocytes, insulin-producing cells and LCSCs. First of all, to certificate the cell fates of LSPCs, the following three features need to be taken into account to perform accurate phenotyping: (1) morphological properties; (2) specific markers; and (3) functional assessment including in vivo transplantation. Secondly, to promote LSPCs differentiation, systematical attention should be paid to inductive materials (such as growth factors and chemical stimulators), progressive materials including intracellular and extracellular signaling pathways, and implementary materials (such as liver enriched transcriptive factors). Accordingly, some recommendations were proposed to standardize, optimize, and enrich the effective production of cholangiocyte-like cells out of LSPCs. At the end, the potential regulating mechanisms for generation of cholangiocytes by LSPCs were carefully analyzed. The differentiation of LSPCs is a gradually progressing process, which consists of three main steps: initiation, progression and accomplishment. It's the unbalanced distribution of affecting materials in each step decides the cell fates of LSPCs.

Entities:  

Keywords:  Biliary differentiation; Cell therapy; Cholangiocytes; Liver stem/progenitor cells; Unbalanced distribution of materials

Mesh:

Substances:

Year:  2013        PMID: 24222945      PMCID: PMC3819537          DOI: 10.3748/wjg.v19.i41.7032

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  90 in total

1.  Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene.

Authors:  E FARBER
Journal:  Cancer Res       Date:  1956-02       Impact factor: 12.701

2.  Efficient generation of functional hepatocyte-like cells from human fetal hepatic progenitor cells in vitro.

Authors:  Weitao Zhang; Weihong Li; Baoqing Liu; Ping Wang; Wen Li; Haiyan Zhang
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

3.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

Authors:  Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

4.  The role of the Wnt family of secreted proteins in rat oval "stem" cell-based liver regeneration: Wnt1 drives differentiation.

Authors:  Jennifer M Williams; Seh-Hoon Oh; Marda Jorgensen; Nicole Steiger; Houda Darwiche; Thomas Shupe; Bryon E Petersen
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

Review 5.  Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies.

Authors:  Frédéric P Lemaigre
Journal:  Gastroenterology       Date:  2009-03-27       Impact factor: 22.682

6.  Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice.

Authors:  Jan S Tchorz; Jochen Kinter; Matthias Müller; Luigi Tornillo; Markus H Heim; Bernhard Bettler
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

7.  A bipotential precursor population for pancreas and liver within the embryonic endoderm.

Authors:  G Deutsch; J Jung; M Zheng; J Lóra; K S Zaret
Journal:  Development       Date:  2001-03       Impact factor: 6.868

8.  Isolation of CD133+ liver stem cells for clonal expansion.

Authors:  C Bart Rountree; Wei Ding; Hein Dang; Colleen Vankirk; Gay M Crooks
Journal:  J Vis Exp       Date:  2011-10-10       Impact factor: 1.355

9.  Human hepatic stem cells from fetal and postnatal donors.

Authors:  Eva Schmelzer; Lili Zhang; Andrew Bruce; Eliane Wauthier; John Ludlow; Hsin-lei Yao; Nicholas Moss; Alaa Melhem; Randall McClelland; William Turner; Michael Kulik; Sonya Sherwood; Tommi Tallheden; Nancy Cheng; Mark E Furth; Lola M Reid
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

10.  Notch signaling regulates bile duct morphogenesis in mice.

Authors:  Julie Lozier; Brent McCright; Thomas Gridley
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

View more
  1 in total

Review 1.  Biliary tract cancer stem cells - translational options and challenges.

Authors:  Christian Mayr; Matthias Ocker; Markus Ritter; Martin Pichler; Daniel Neureiter; Tobias Kiesslich
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.